Advances In Eyecare

Last year, it was announced that Optos were teaming up with the company Amydis in developing retinal screening for Alzheimer’s disease. Amydis have developed a technique that allows the visualisation of amyloid build up in the retina. Amyloid is a useful biomarker which is found in increasing amounts as the disease progresses. In this interview, we speak to Anne-Marie Cairns to find out more about the technique and the possible future role that optometrists might have in the early detection of Alzheimer’s disease.